TY - JOUR
T1 - Early markers of cystic fibrosis structural lung disease
T2 - Follow-up of the ACFBAL cohort
AU - Wijker, Naomi E.
AU - Vidmar, Suzanna
AU - Grimwood, Keith
AU - Sly, Peter D.
AU - Byrnes, Catherine A.
AU - Carlin, John B.
AU - Cooper, Peter J.
AU - Robertson, Colin F.
AU - Massie, Richard (John)
AU - Kemner van de Corput, Mariette P.C.
AU - Cheney, Joyce
AU - Tiddens, Harm A.W.M.
AU - Wainwright, Claire E.
AU - Australasian Cystic Fibrosis Bronchoalveolar Lavage (ACFBAL) and Follow-up of the ACFBAL (CF-FAB)
AU - George, Narelle
AU - Carzino, Rosemary
AU - Moodie, Marj
AU - Armstrong, David S.
AU - Martin, A. (James)
AU - Whitehead, Bruce
AU - Rogers, Geraint
AU - Wark, Peter
PY - 2020/4/1
Y1 - 2020/4/1
N2 - Little is known about early predictors of later cystic fibrosis (CF) structural lung disease. This study examined early predictors of progressive structural lung abnormalities in children who completed the Australasian CF Bronchoalveolar Lavage (ACFBAL) clinical trial at age 5-years and participated in an observational follow-up study (CF-FAB). Eight Australian and New Zealand CF centres participated in CF-FAB and provided follow-up chest computed-tomography (CT) scans for children who had completed the ACFBAL study with baseline scans at age 5-years. CT scans were annotated using PRAGMA-CF scoring. Ordinal regression analysis and linear regression were used to investigate associations between PRAGMA-CF (Perth–Rotterdam Annotated Grid Morphometric Analysis for CF) outcomes at follow-up and variables measured during the ACFBAL study. 99 out of 157 ACFBAL children (mean±SD age 13±1.5 years) participated in the CF-FAB study. The probability of bronchiectasis at follow-up increased with airway disease severity on the baseline CT scan. In multiple regression (retaining factors at p<0.05) the extent of bronchiectasis at follow-up was associated with baseline atelectasis (OR 7.2, 95% CI 2.4–22; p≼ 0.001), bronchoalveolar lavage (BAL) log2 interleukin (IL)-8 (OR 1.2, 95% CI 1.05–1.5; p=0.010) and body mass index z-score (OR 0.49, 95% CI 0.24–1.00; p=0.05) at age 5 years. Percentage trapped air at follow-up was associated with BAL log2 IL-8 (coefficient 1.3, 95% CI 0.57–2.1; p<0.001) at age 5 years. The extent of airway disease, atelectasis, airway inflammation and poor nutritional status in early childhood are risk factors for progressive structural lung disease in adolescence.
AB - Little is known about early predictors of later cystic fibrosis (CF) structural lung disease. This study examined early predictors of progressive structural lung abnormalities in children who completed the Australasian CF Bronchoalveolar Lavage (ACFBAL) clinical trial at age 5-years and participated in an observational follow-up study (CF-FAB). Eight Australian and New Zealand CF centres participated in CF-FAB and provided follow-up chest computed-tomography (CT) scans for children who had completed the ACFBAL study with baseline scans at age 5-years. CT scans were annotated using PRAGMA-CF scoring. Ordinal regression analysis and linear regression were used to investigate associations between PRAGMA-CF (Perth–Rotterdam Annotated Grid Morphometric Analysis for CF) outcomes at follow-up and variables measured during the ACFBAL study. 99 out of 157 ACFBAL children (mean±SD age 13±1.5 years) participated in the CF-FAB study. The probability of bronchiectasis at follow-up increased with airway disease severity on the baseline CT scan. In multiple regression (retaining factors at p<0.05) the extent of bronchiectasis at follow-up was associated with baseline atelectasis (OR 7.2, 95% CI 2.4–22; p≼ 0.001), bronchoalveolar lavage (BAL) log2 interleukin (IL)-8 (OR 1.2, 95% CI 1.05–1.5; p=0.010) and body mass index z-score (OR 0.49, 95% CI 0.24–1.00; p=0.05) at age 5 years. Percentage trapped air at follow-up was associated with BAL log2 IL-8 (coefficient 1.3, 95% CI 0.57–2.1; p<0.001) at age 5 years. The extent of airway disease, atelectasis, airway inflammation and poor nutritional status in early childhood are risk factors for progressive structural lung disease in adolescence.
KW - Cystic Fibrosis
KW - Lung Disease
KW - Children
UR - http://www.scopus.com/inward/record.url?scp=85082759018&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/NHMRC/9937868
UR - http://purl.org/au-research/grants/NHMRC/351541
UR - http://purl.org/au-research/grants/NHMRC/1044829
U2 - 10.1183/13993003.01694-2019
DO - 10.1183/13993003.01694-2019
M3 - Article
C2 - 31949117
AN - SCOPUS:85082759018
SN - 0903-1936
VL - 55
JO - European Respiratory Journal
JF - European Respiratory Journal
IS - 4
M1 - 1901694
ER -